AIMS SIG

Objectives

The Application and Implementation of Methodologies in Statistics (AIMS) Special Interest Group (SIG) objective is to support PSI Committees and PSI/EFSPI Special Interest Groups (SIGs) with the technological application and implementation of statistics.  To develop understanding of new analytical tools and approaches to share with PSI & EFSPI members via appropriate forums.  To ensure PSI & EFSPI members are supported with understanding the requirements for the implementation of industry data standards. 

For 2019/2020, our main objectives are:

  1. Key objective: Automation of reporting: Most companies are working towards a time from DB lock to High Level results of 24 hours with just 5 days for the Stats analysis to be complete.  Therefore we’d look to ways to assist with this through the use of technology.   
  2. Key objective: Data visualization:  Looks at technology to enhance visualization of data throughout the study
  3. Work with statisticians and statistical programmers to educate them on Data Science Tools (such as R, GitHub etc)
  4. Bridging the gap between SAS and other software (for example, SAS processes / global macros and do it in Git / GitHub)
  5. Assist other SIGS implement their needs in software/training/support. – Reach out to SIGS (including data science SIG) and ask if we can help with any of their projects & the implementation of them.
  6. R Validation Hub – Continue the work on the Hub project improving the website, and production of R metrics/ tests/ validation documentation


Who we are

The AIMS SIG was formed in May 2016 and currently consists of the following team members:

Name

Company

Role

Lyn Taylor

Phastar, UK

Chair

Andy Nicholls 

GSK, UK R validation Hub Chair
Chris Toffis
SQN Clinical, UK
Jules Hernandez-Sanchez
Roche, UK            

Yann Roberts

Servier, France

 

Michael Grayer

Floating Point Statistics, UK

 

Martin Brown
PPD, UK

Karma Tarap

JnJ, UK

Mark Bynens

JnJ, UK



We also have a wider team of experts in the use of R.  The R Validation Hub are working on the collection of metrics for R packages and the production of guidance information on the use of R in the pharmaceutical industry.  See the following for more information:  https://www.pharmar.org 



How to get in touch

If you are interested in joining the AIMS SIG, then please contact Lyn Taylor: lyn.taylor@phastar.com
If you are interested in R, and joining the R validation Hub contact: psi.aims.r.validation@gmail.com



Latest News

AIMS was awarded funding from the R-Consortium in June 2018 to create of an online repository for R package validation in accordance with regulatory standards.  The desire to use R in the pharmaceutical industry is evident due to it being a very powerful object-orientated language, able to produce analyses and high quality graphics and being open source hence readily enabling bespoke extensions.  It can be used for high performance computing and allows easy integration with other software.  It can also be used for complex analyses which is especially important when these analyses are not available in SAS.  The AIMS SIG acted as a springboard for the R Validation Hub initiative which has now grown into it's own committee with involvement of over 40 companies.   For more information see: https://www.pharmar.org/  If you are interested in contributing to this project please contact: psi.aims.r.validation@gmail.com.  

The team are now looking at the use of gt for production of TFLs to see if using R can make study reporting and CSR creation more efficient.  SPIN article to follow!

R Training and Help

Substantial free training is available for R. Some of our favourite sources are listed below.

Latest News


Show all news

EventsFuture Events


bayerlogoresized

Principal Statistician

read more...

bayerlogoresized

Senior Statistician

read more...

AZ_RGB_H_COL

Senior/Principal Early-Phase Clinical Statistician, R&D Oncology Unit

read more...

GSK_LOS_3D_CMYK_MY

Recruiting for a variety of statistician and statistical programming opportunities

read more...